JPH09511488A - 酸性活性物質を有する経口投与形物およびその製造方法 - Google Patents
酸性活性物質を有する経口投与形物およびその製造方法Info
- Publication number
- JPH09511488A JPH09511488A JP7519849A JP51984995A JPH09511488A JP H09511488 A JPH09511488 A JP H09511488A JP 7519849 A JP7519849 A JP 7519849A JP 51984995 A JP51984995 A JP 51984995A JP H09511488 A JPH09511488 A JP H09511488A
- Authority
- JP
- Japan
- Prior art keywords
- active substance
- dosage form
- oral dosage
- colestipol
- ibuprofen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.酸性活性物質用の担体を有する経口投与形物において、該活性物質は三級ア ミノ基を有するポリマーにイオン結合した少なくとも1つの遊離カルボキシ基を 有し、該ポリマーはコレスチポールまたは塩酸コレスチポールであることを特徴 とする経口投与形物。 2.前記活性物質が非ステロイド系のリウマチ治療薬のグループに属することを 特徴とする請求項1記載の経口投与形物。 3.前記活性物質がアントラン酸、酢酸またはプロピオン酸の誘導体いずれかに 属することを特徴とする請求項2記載の経口投与形物。 4.前記活性物質がラセミ化合物を表すことを特徴とする請求項1記載の経口投 与形物。 5.前記活性物質が少なくとも1つのキラル中心を有し、鏡像体に関して実質的 に純粋な形で存在することを特徴とする請求項1記載の経口投与形物。 6.前記活性物質がイブプロフェンであることを特徴とする請求項3記載の経口 投与形物。 7.前記活性物質がS(+)イブプロフェンであることを特徴とする請求項6記 載の経口投与形物。 8.前記活性物質がバルプロ酸であることを特徴とする請求項1記載の経口投与 形物。 9.前記活性物質がカプトプリルであることをことを特徴とする請求項1記載の 経口投与形物。 10.噛むことのできる錠剤またはチューインガムであることを特徴とする請求 項1記載の経口投与形物。 11.カプセルまたは錠剤であることを特徴とする請求項1記載の経口投与形物 。 12.前記活性物質が溶媒を含まない液相からコレスチポールまたは塩酸コレス チポールの塩基性基に対して結合させることを特徴とする請求項1〜11の一項以 上に記載の経口投与形物の製造方法。 13.前記活性物質が融点降下用の補助剤と混合し、それを前記混合物からのコ レスチポールまたは塩酸コレスチポールの塩基性基と結合させることを特徴と する請求項1〜11の一項以上に記載の経口投与形物の製造方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4402379A DE4402379C2 (de) | 1994-01-27 | 1994-01-27 | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
| DE4402379.0 | 1994-01-27 | ||
| PCT/EP1994/004082 WO1995020394A1 (de) | 1994-01-27 | 1994-12-08 | Orale arzneiform enthaltend colestipol als träger mit sauren wirkstoffen und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH09511488A true JPH09511488A (ja) | 1997-11-18 |
| JP3701971B2 JP3701971B2 (ja) | 2005-10-05 |
Family
ID=6508812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51984995A Expired - Fee Related JP3701971B2 (ja) | 1994-01-27 | 1994-12-08 | 酸性活性物質を有する経口投与形物およびその製造方法 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5858344A (ja) |
| EP (1) | EP0741574B1 (ja) |
| JP (1) | JP3701971B2 (ja) |
| KR (1) | KR100439311B1 (ja) |
| AT (1) | ATE218371T1 (ja) |
| AU (1) | AU697353B2 (ja) |
| CA (1) | CA2182417C (ja) |
| CZ (1) | CZ291006B6 (ja) |
| DE (2) | DE4402379C2 (ja) |
| DK (1) | DK0741574T3 (ja) |
| ES (1) | ES2177622T3 (ja) |
| FI (1) | FI116880B (ja) |
| HU (1) | HU223317B1 (ja) |
| IL (1) | IL112435A (ja) |
| MY (1) | MY113340A (ja) |
| NO (1) | NO963143L (ja) |
| NZ (1) | NZ277777A (ja) |
| PL (1) | PL315619A1 (ja) |
| PT (1) | PT741574E (ja) |
| SK (1) | SK97296A3 (ja) |
| WO (1) | WO1995020394A1 (ja) |
| ZA (1) | ZA95638B (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022259848A1 (ja) | 2021-06-07 | 2022-12-15 | 国立大学法人筑波大学 | 高分子化バルプロ酸及びその使用 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6403367B1 (en) * | 1994-07-07 | 2002-06-11 | Nanogen, Inc. | Integrated portable biological detection system |
| DE19615820A1 (de) * | 1996-04-06 | 1997-10-09 | Holger Specht | Zahnpflegemittel und Verfahren zu seiner Herstellung |
| US20030180249A1 (en) * | 2002-03-18 | 2003-09-25 | Khanna Satish Chandra | Dosage forms for hygroscopic active ingredients |
| ES2664895T3 (es) | 2006-11-07 | 2018-04-23 | The Procter & Gamble Company | Composiciones que contienen fibra y métodos de fabricación y uso de las mismas |
| US7767248B2 (en) * | 2007-02-02 | 2010-08-03 | Overly Iii Harry J | Soft chew confectionary with high fiber and sugar content and method for making same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ191762A (en) * | 1978-10-19 | 1982-09-14 | Merck & Co Inc | Hypocholesteremic composition containing cholesterol synthesis inhibitor and anion exchange resin |
| US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
| ATE22804T1 (de) * | 1982-03-01 | 1986-11-15 | Efamol Ltd | Pharmazeutische zusammensetzung. |
| US4996047A (en) * | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| EP0409432A3 (en) * | 1989-07-20 | 1991-12-11 | Warner-Lambert Company | Confectionery delivery system |
| CA2040865C (en) * | 1990-05-15 | 2002-07-23 | James L. Bergey | Method for preventing, stabilizing or causing regression of atherosclerosis employing a combination of a cholesterol lowering drug and an ace inhibitor |
-
1994
- 1994-01-27 DE DE4402379A patent/DE4402379C2/de not_active Expired - Fee Related
- 1994-12-08 DK DK95904434T patent/DK0741574T3/da active
- 1994-12-08 DE DE59410133T patent/DE59410133D1/de not_active Expired - Lifetime
- 1994-12-08 CZ CZ19962213A patent/CZ291006B6/cs not_active IP Right Cessation
- 1994-12-08 US US08/693,101 patent/US5858344A/en not_active Expired - Lifetime
- 1994-12-08 PT PT95904434T patent/PT741574E/pt unknown
- 1994-12-08 JP JP51984995A patent/JP3701971B2/ja not_active Expired - Fee Related
- 1994-12-08 PL PL94315619A patent/PL315619A1/xx unknown
- 1994-12-08 NZ NZ277777A patent/NZ277777A/en not_active IP Right Cessation
- 1994-12-08 WO PCT/EP1994/004082 patent/WO1995020394A1/de not_active Ceased
- 1994-12-08 HU HU9602041A patent/HU223317B1/hu not_active IP Right Cessation
- 1994-12-08 KR KR1019960704025A patent/KR100439311B1/ko not_active Expired - Fee Related
- 1994-12-08 ES ES95904434T patent/ES2177622T3/es not_active Expired - Lifetime
- 1994-12-08 AT AT95904434T patent/ATE218371T1/de active
- 1994-12-08 SK SK972-96A patent/SK97296A3/sk unknown
- 1994-12-08 AU AU13127/95A patent/AU697353B2/en not_active Ceased
- 1994-12-08 EP EP95904434A patent/EP0741574B1/de not_active Expired - Lifetime
- 1994-12-08 CA CA002182417A patent/CA2182417C/en not_active Expired - Fee Related
-
1995
- 1995-01-24 IL IL11243595A patent/IL112435A/en not_active IP Right Cessation
- 1995-01-26 ZA ZA95638A patent/ZA95638B/xx unknown
- 1995-01-26 MY MYPI95000183A patent/MY113340A/en unknown
-
1996
- 1996-07-26 FI FI962985A patent/FI116880B/fi not_active IP Right Cessation
- 1996-07-26 NO NO963143A patent/NO963143L/no unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022259848A1 (ja) | 2021-06-07 | 2022-12-15 | 国立大学法人筑波大学 | 高分子化バルプロ酸及びその使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3701971B2 (ja) | 2005-10-05 |
| DE59410133D1 (de) | 2002-07-11 |
| PL315619A1 (en) | 1996-11-25 |
| US5858344A (en) | 1999-01-12 |
| KR970700505A (ko) | 1997-02-12 |
| ES2177622T3 (es) | 2002-12-16 |
| FI962985A0 (fi) | 1996-07-26 |
| FI116880B (fi) | 2006-03-31 |
| KR100439311B1 (ko) | 2005-08-17 |
| ATE218371T1 (de) | 2002-06-15 |
| DE4402379A1 (de) | 1995-08-03 |
| EP0741574B1 (de) | 2002-06-05 |
| AU1312795A (en) | 1995-08-15 |
| DK0741574T3 (da) | 2002-09-23 |
| IL112435A0 (en) | 1995-03-30 |
| MY113340A (en) | 2002-01-31 |
| CA2182417C (en) | 2007-04-17 |
| HUT74434A (en) | 1996-12-30 |
| AU697353B2 (en) | 1998-10-01 |
| EP0741574A1 (de) | 1996-11-13 |
| CZ221396A3 (en) | 1997-01-15 |
| WO1995020394A1 (de) | 1995-08-03 |
| PT741574E (pt) | 2002-11-29 |
| HU223317B1 (hu) | 2004-05-28 |
| FI962985L (fi) | 1996-07-26 |
| DE4402379C2 (de) | 1997-09-25 |
| CA2182417A1 (en) | 1995-08-03 |
| HU9602041D0 (en) | 1996-09-30 |
| NZ277777A (en) | 1997-01-29 |
| SK97296A3 (en) | 1997-04-09 |
| NO963143D0 (no) | 1996-07-26 |
| IL112435A (en) | 1999-01-26 |
| ZA95638B (en) | 1995-10-25 |
| NO963143L (no) | 1996-09-24 |
| CZ291006B6 (cs) | 2002-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0253104B1 (en) | Controlled release bases for pharmaceuticals | |
| JP4017661B2 (ja) | 重合体マトリックス中の作用物質の固溶体の形の作用物質調剤の製法及び該製法により製造された作用物質調剤 | |
| US5855915A (en) | Tablets or biologically acceptable implants for long-term antiinflammatory drug release | |
| US20070231382A1 (en) | Pharmaceutical composition | |
| JPS62106011A (ja) | 徐放性錠剤 | |
| PT1449531E (pt) | Formulações opióides administráveis por via oral e obtidas por extrusão de uma massa fundida. | |
| IE60508B1 (en) | Controlled release combination of carbidopa/levodopa | |
| JP2011144194A (ja) | 医薬組成物 | |
| AU2002213900A1 (en) | Pharmaceutical compositions | |
| JP3701971B2 (ja) | 酸性活性物質を有する経口投与形物およびその製造方法 | |
| EP1238663A2 (en) | Mixed hydrophilic gels as controlled release vehicles or floating dispersants | |
| HK1087336B (en) | Pharmaceutical composition comprising lumiracoxib | |
| ZA200300555B (en) | Pharmaceutical compositions. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040629 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041021 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20050106 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050513 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050705 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050715 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080722 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090722 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090722 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100722 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110722 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110722 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120722 Year of fee payment: 7 |
|
| LAPS | Cancellation because of no payment of annual fees |